Biomarkers of Aging
2025 Conference

RETRO BIO

Joe Betts-LaCroix, a scientist turned entrepreneur with roots at Harvard, MIT, and Caltech, is CEO of Retro Biosciences and has founded multiple venture-backed startups, including OQO and Vium, focused on technological and biomedical innovation, with a mission to extend healthy human lifespan.

NORTHEASTERN UNIVERSITY

Albert-Laszlo Barabasi is the Robert Gray Dodge Professor of Network Science and a Distinguished University Professor at Northeastern University, where he directs the Center for Complex Network Research.

HARVARD MEDICAL SCHOOL

Fei Chen, a core member of the Broad Institute and associate professor at Harvard, develops innovative tools integrating single-cell genomics with spatial and temporal analysis to uncover how and when cell types function within intact tissues.

AARP CHAIR IN GERONTOLOGY
USC DAVIS SCHOOL OF GERONTOLOGY

Eileen M. Crimmins, the AARP Chair in Gerontology at USC, is renowned for her research on how socioeconomic factors influence life expectancy and health outcomes.

NATIONAL INSTITUTE OF AGING

Dr. Luigi Ferrucci, a geriatrician and epidemiologist, is Chief of the Longitudinal Studies Section at the NIA and Director of the Baltimore Longitudinal Study on Aging, focusing on the biological pathways of physical and cognitive decline in aging.

BIOAGE LABS

Kristen, co-founder and CEO of BioAge since 2015, is a biotech executive with a PhD in Medical Biophysics and expertise in aging biology, genetics, and bioinformatics, known for her work in building discovery platforms and advising biotech companies.

ALTOS LABS

Dr. Steve Horvath, Principal Investigator at Altos Labs, is a leading researcher in biogerontology and epigenetic biomarkers of aging, renowned for developing the first epigenetic clocks and the WGCNA method, with a career spanning UCLA and numerous high-impact scientific contributions.

JUNTENDO UNIVERSITY

Professor Horie, Chair of Urology, Data Science, and Innovative Longevity Medicine at Juntendo University, is a dual-licensed physician in Japan and the U.S. with specialized training in Urology and Nephrology from the University of Tokyo and UT Southwestern.

UNIVERSITY OF PARIS DESCARTES

Guido Kroemer, a leading cell biologist and highly cited researcher, is renowned for his discovery that mitochondrial membrane permeabilization is a key step in programmed cell death and is a member of several prominent European scientific academies.

NATIONAL UNIVERSITY OF SINGAPORE
CHI LONGEVITY FOUNDER

Dr. Maier is a Professor in Medicine and Healthy Ageing and the Co-Director of Center for Healthy Longevity at the National University of Singapore and a Fellow of the Royal Australasian College of Physicians.

TORNADO THERAPUTICS

Joan Mannick, CEO and Co-Founder of Tornado Therapeutics, is a physician-scientist and biotech leader specializing in aging-related diseases, with a career spanning leadership roles at Life Biosciences, resTORbio, Novartis, Genzyme, and academic positions at Harvard and UMass Medical Schools.

DUKE UNIVERSITY

Terrie E. Moffitt, Ph.D., is a leading expert in developmental psychology and behavioral science, serving as a professor at Duke University and King’s College London, with a focus on longitudinal research, mental disorders, antisocial behavior, neuropsychology, and genomics.

BUCK INSTITUTE FOR RESEARCH ON AGING

Nathan D. Price is a systems biologist and bioengineer specializing in the use of systems biology and AI to advance human health, aging, and scientific wellness, and serves as co-director of the Center for Human Healthspan at the Buck Institute and affiliate faculty at the University of Washington.

BOSTON UNIVERSITY

Paola Sebastiani is a biostatistician and professor at Boston University whose research focuses on genetic epidemiology and Bayesian modeling to develop prognostic models for understanding complex traits.

RWT AACHEN MEDICAL SCHOOL

Wolfgang Wagner is Director of the Institute for Stem Cell Biology at RWTH Aachen University Medical School (Germany).

UNIVERSITY OF TORONTO

Dr. Wang, Chief Artificial Intelligence Scientist at the University Health Network and Canada CIFAR AI Chair at the Vector Institute, conducts research at the intersection of machine learning and computational biology.

INSILICO MEDICINE

Alex Zhavoronkov is a biotechnology entrepreneur and aging researcher, founder and CEO of Insilico Medicine, and director of the UK-based Biogerontology Research Foundation, with work spanning regenerative medicine and the economics of aging.